Home » Authors » Brady Huggett

Articles by Brady Huggett

Cypress Bioscience Raises $10.3M For Milnacipran Phase III Program

March 28, 2003

By Brady Huggett

Cypress Bioscience Raises $10.3M For Milnacipran Phase III Program

March 28, 2003

By Brady Huggett

Alteon Raises $7.7M Privately For ALT-711, Other Products

March 27, 2003

By Brady Huggett

Merck Accepts Kalypsys Invite, Ends Up Signing Platform Deal

March 27, 2003

By Brady Huggett

Merck Accepts Kalypsys Invite, Ends Up Signing Platform Deal

March 27, 2003

By Brady Huggett

Alteon Raises $7.7M Privately For ALT-711, Other Products

March 27, 2003

By Brady Huggett

Biopure Plans To Raise $13.4M While Awaiting Word From FDA

March 26, 2003

By Brady Huggett

Biopure Plans To Raise $13.4M While Awaiting Word From FDA

March 26, 2003

By Brady Huggett

Dermatology Meeting Brings Together Psoriasis Competitors

March 25, 2003

By Brady Huggett

Dermatology Meeting Brings Together Psoriasis Competitors

March 25, 2003

By Brady Huggett

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 8, 2025.
100 days of uncertainty
BioWorld
The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...
PIKfyve enzyme is target to ‘starve’ pancreatic cancer cells
BioWorld
A metabolic vulnerability of pancreatic ductal adenocarcinoma (PDAC) could be used to address this type of cancer that often resists treatments. Scientists at the...
AACR 2025: Induced proximity strategy, beyond degraders
BioWorld
Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...